This protocol addresses patients with aneurysmal subarachnoid hemorrhage (aSAH) in whom the ruptured aneurysm has been secured. With the aneurysm treated, preventing venous thromboembolism (VTE) becomes a key clinical priority.
A structured VTE prophylaxis strategy is recommended for this population. The protocol specifies the intervention type, selection criteria, and conditions under which each option applies — details are in the full regimen.
DOI: 10.1161/str.0000000000000436
In patients with aSAH whose ruptured aneurysm has been secured, pharmacological or mechanical venous thromboembolism (VTE) prophylaxis is recommended to reduce the risk for VTE.
A small RCT of enoxaparin 40 mg SC injection once daily in aSAH after aneurysm treatment found that enoxaparin did not increase bleeding and may have decreased the VTE rate but had no overall effect on outcome.
View source ↗